BSE Live
Dec 04, 10:49Prev. Close
662.75
Open Price
662.75
Bid Price (Qty.)
659.50 (100)
Offer Price (Qty.)
660.20 (1)
NSE Live
Dec 04, 10:49Prev. Close
663.70
Open Price
662.80
Bid Price (Qty.)
659.45 (2)
Offer Price (Qty.)
659.80 (8)
| Key Financial Ratios of Anthem Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 9.05 | 6.61 | 6.77 | 462.98 | 323.43 | |
| Diluted EPS (Rs.) | 9.01 | 6.61 | 6.77 | 462.95 | 323.41 | |
| Cash EPS (Rs.) | 10.45 | 8.16 | 7.88 | 528.41 | 393.31 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 44.24 | 34.58 | 30.53 | 1,542.59 | 824.83 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 44.24 | 34.58 | 30.53 | 1,542.59 | 824.83 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 32.92 | 25.35 | 18.53 | 1,402.93 | 1,300.29 | |
| PBDIT/Share (Rs.) | 14.28 | 10.29 | 8.88 | 700.11 | 524.41 | |
| PBIT/Share (Rs.) | 12.89 | 8.83 | 7.76 | 634.30 | 450.87 | |
| PBT/Share (Rs.) | 12.72 | 8.67 | 8.73 | 622.80 | 430.87 | |
| Net Profit/Share (Rs.) | 9.05 | 6.70 | 6.76 | 462.60 | 319.76 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 43.37 | 40.59 | 47.91 | 49.90 | 40.33 | |
| PBIT Margin (%) | 39.14 | 34.84 | 41.88 | 45.21 | 34.67 | |
| PBT Margin (%) | 38.65 | 34.19 | 47.09 | 44.39 | 33.13 | |
| Net Profit Margin (%) | 27.50 | 26.43 | 36.48 | 32.97 | 24.59 | |
| Return on Networth / Equity (%) | 20.46 | 19.38 | 22.14 | 29.98 | 38.76 | |
| Return on Capital Employed (%) | 28.31 | 24.42 | 24.05 | 39.87 | 51.08 | |
| Return on Assets (%) | 17.85 | 16.12 | 19.35 | 25.07 | 26.24 | |
| Total Debt/Equity (X) | 0.04 | 0.09 | 0.07 | 0.03 | 0.14 | |
| Asset Turnover Ratio (%) | 0.71 | 0.66 | 0.59 | 0.93 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.72 | 4.78 | 8.65 | 4.92 | 2.16 | |
| Quick Ratio (X) | 4.55 | 4.08 | 7.80 | 4.66 | 2.04 | |
| Inventory Turnover Ratio (X) | 6.69 | 8.32 | 11.27 | 26.40 | 31.46 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
14.08.2025
Anthem Bio shares surge 5 percent on strong show in CRDMO and specialty business
21.07.2025
Anthem Biosciences shares close with 28% gains on market debut, valued at Rs 41,017 crore
21.07.2025
Anthem Biosciences shares list at 27% premium over IPO price on NSE; should you buy, sell or hold?
21.07.2025